Patients with cardiac implantable electronic devices (CIED) and endovascular infection represent a difficult management group. The explantation of an implantable cardioverter-defibrillator (ICD) system deprives the patient of the protection against life-threatening ventricular tachyarrhythmias. In this study, we describe feasibility and clinical outcomes of bridging with temporary dual-coil ICD lead and external ICD following the extraction of a CIED due to endovascular infection and compare the performance of this approach to other available options. 
| INTRODUCTION
The mainstay of treatment in patients with cardiac implantable electronic device (CIED)-related infection is removal of all hardware. 1 The benefit of providing backup defibrillation protection after explantation of a right ventricular shock lead varies according to patient's risk of sudden cardiac death (SCD). In danger are patients in secondary SCD prevention, and those with earlier implantable cardioverter-defibrillator (ICD) therapies, relative to primary prevention patients who have never received appropriate ICD therapies. as the most challenging to extract and was hence extracted first; Furthermore, in a similar setting, Dell'Era et al showed efficacious delivery of ATP and shock from a system consisting of a temporary dual-coil active-fixation DF4 lead, connected to an external ICD with passive-can shock configuration. 6 Our case demonstrates an additional method of controlling heart rhythm with VVI overdrive pacing, which has not been described in the aforementioned reports.
The noteworthy benefit of the temporary external ICD system over WCD is that it automatically starts treatment, whereas the latter is interactive and significantly depends on patient compliance.
Moreover, an external ICD shares the same capacities as a traditional ICD, enabling bradycardia pacing, overdrive pacing, and ATP therapies. These are unavailable in the treatment choices involving "exter- 
F I G U R E 1 A, ICD lead implanted via a percutaneous puncture of the left subclavian vein, sutured to the skin, and connected to ICD unit; B, Chest x-ray after lead extraction and temporary dual-coil ICD lead implantation bridged with screwed-in temporary lead for 11.1 AE 9.7 days and retrospectively followed up for a mean period of 25.2 months: Eight patients (15.4%) developed vegetations on their temporary lead; one temporary lead dislodged with sudden loss of capture; and one patient developed a CIED reinfection after 21 months of follow-up. 9 Undoubtedly, a prospective study would be required to fully assess the long-term safety of temporary lead bridging. Importantly, in the above-mentioned studies by Macia z g et al and Perrin et al, up to 20% of patients had an infected ICD system, 7,9 whereas in the study by Amraoui et al, ICD patients were excluded from analysis. 
